WAI CHUN BIOTEC(00660): Possible delay in publishing full-year performance.
Weijun Biotechnology (00660) issued an announcement that the company's Chief Financial Officer will be on leave from September 14, 2024 due to family reasons.
WAI CHUN BIOTEC (00660) announces that the company's Chief Financial Officer has resigned from September 14, 2024 due to personal reasons, causing hindrances in providing information and documents to the auditors. As a result, the company needs additional time to finalize the audited financial results for the year ending June 30, 2024, and it may be delayed beyond the original announcement date of September 30, 2024.
The company is working closely with the auditors to provide all required information and documents to expedite the auditing process. However, the expected announcement date for the annual results will need to be further determined with the auditors and will be announced separately.
Related Articles

How to predict the market trend for the New Year? How to strategize for opportunities next year? The strategies from the top ten securities firms are here.

Hong Kong-listed company 18C Corporation is making waves in the Physical AI sector by holding a hearing on May 1st.

FENBI (02469) partners with Huatu strategically to reshape the valuation logic of top-level collaboration in vocational education.
How to predict the market trend for the New Year? How to strategize for opportunities next year? The strategies from the top ten securities firms are here.

Hong Kong-listed company 18C Corporation is making waves in the Physical AI sector by holding a hearing on May 1st.

FENBI (02469) partners with Huatu strategically to reshape the valuation logic of top-level collaboration in vocational education.

RECOMMEND

Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
12/12/2025

Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
12/12/2025

Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
12/12/2025


